China · Series B startup
2 rounds we have observed, with the 6 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$97Mraised across 2 rounds since 2018, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Reported by FinSMEs
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Oncologie's investors include Nan Fung Life Sciences, Pivotal BioVentures China, Volcanics, China Merchant Bank and Panacea Venture Healthcare, and 1 more on record. Nan Fung Life Sciences led its latest round.
Oncologie has raised $97M across 2 rounds since 2018.
Oncologie's most recent round was a Series B of $80M in Jun 2019, led by Nan Fung Life Sciences.
Its most recent round, $80M in Jun 2019, is also its largest on record.
Oncologie's first round on record, in Jun 2018, was backed by Volcanics, China Merchant Bank and Pivotal bioVenture Partners China/ Nan Fung.
Oncologie's latest named round is a Series B, in Jun 2019.
Oncologie is based in China.
Nan Fung Life Sciences led the Series B in 2019.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
China · 
